Browse by Journal Title

2009

New approaches to pathogenesis and management of hypertension.
Ritz, E., Krum, H., Schlaich, M., Whitbourn, R., Sobotka, P.A., Sadowski, J., Bartus, K., Kapelak, B., Walton, A., Sievert, H., Thambar, S., Abraham, W.T., Esler, M., Wang, Y., Tsun, Z., Machnik, A., Neuhofer, W., Jantsch, J., Dahlmann, A., Tammela, T., Machura, K., Park, J.K., Beck, F.X., Mueller, D.N., Derer, W., Goss, J., Ziomber, A., Dietsch, P., Wagner, H., van Rooijen, N., Kurtz, A., Hilgers, K.F., Alitalo, K., Eckardt, K.U., Luft, F.C., Kerjaschki, D. and Titze, J.
Clinical Journal of the American Society of Nephrology 4 (12): 1886-1891. December 2009

More mixed messages in terms of salt.
Luft, F.C.
Clinical Journal of the American Society of Nephrology 4 (11): 1699-1700. November 2009

2007

Niacin lowers serum phosphate and increases HDL cholesterol in dialysis patients.
Mueller, D., Mehling, H., Otto, B., Bergmann-Lips, R., Luft, F.C., Jordan, J. and Kettritz, R.
Clinical Journal of the American Society of Nephrology 2 (6): 1249-1254. November 2007

Vasopressin, urine concentration, and hypertension: a new perspective on an old story.
Luft, F.C.
Clinical Journal of the American Society of Nephrology 2 (2): 196-197. March 2007

2006

Direct renin inhibition with aliskiren in hypertension and target organ damage.
Mueller, D.N. and Luft, F.C.
Clinical Journal of the American Society of Nephrology 1 (2): 221-228. March 2006